Aytu is definitely oneof the cheapest Biotechs out
Post# of 124
AYTU – Expanding Men’s Urology Portfolio...... By Zacks Small Cap Research
May 25, 2016 4:30 PM
http://finance.yahoo.com/news/aytu-expanding-...00356.html
VALUATION AND RECOMMENDATION
We are initiating coverage on Aytu Bioscience (AYTU) with a Buy rating and a price target of $1.30/share.